Second sight medical products inc (EYES)
Income statement / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Net sales

497

472

1,282

1,128

1,767

2,246

1,907

976

-

1,610

2,236

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

124

364

933

731

1,600

1,784

836

668

-

1,001

1,127

-

-

-

-

-

-

-

-

-

-

-

-

-

Net sales

-

-

-

-

-

-

-

-

-

-

-

1,009

-

1,180

1,037

1,053

-

2,227

2,661

-

-

-

-

-

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

1,127

-

2,615

3,241

912

-

757

1,569

-

-

-

-

-

Net sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

609

611

656

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

416

993

727

Gross profit

373

108

349

397

167

462

1,071

308

1,247

609

1,109

-118

-2,593

-1,435

-2,204

141

1,094

1,470

1,092

0

99

192

-381

-70

Operating expenses:
Research and development, net of grants

4,145

3,379

3,436

2,183

2,437

2,672

2,422

2,474

2,271

1,826

1,949

1,847

2,081

1,588

916

762

1,592

593

849

1

1,361

1,419

1,220

1,039

Clinical and regulatory, net of grants

-

862

536

-

-

964

1,126

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Clinical and regulatory

-

-

-

1,006

-

-

-

1,348

-

629

684

-

-

-

-

-

-

-

-

-

-

-

-

-

Clinical and regulatory

-

-

-

-

-

-

-

-

-

-

-

614

-

609

568

778

-

984

892

-

-

-

-

-

Clinical and regulatory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

630

712

594

Selling and marketing

1,001

1,308

1,689

2,103

2,406

3,040

2,879

3,011

2,512

2,375

2,447

2,235

2,516

2,262

2,199

2,012

4,503

2,132

2,298

1

2,154

1,607

1,828

1,254

General and administrative

2,343

2,178

2,256

2,449

2,484

2,332

2,632

3,244

2,762

2,528

2,901

2,741

2,445

2,605

2,620

2,410

3,798

2,423

2,000

1

1,463

2,184

1,420

1,497

Impairment charge

-

-

-

2,424

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring charges

-

-

873

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

8,499

7,727

8,790

10,165

9,044

9,008

9,059

10,077

8,680

7,358

7,981

7,437

7,790

7,064

6,303

5,962

11,527

6,132

6,039

5

5,664

5,841

5,181

4,385

Loss from operations

-8,126

-7,619

-8,441

-9,768

-8,877

-8,546

-7,988

-9,769

-7,433

-6,749

-6,872

-7,555

-10,383

-8,499

-8,507

-5,821

-10,433

-4,662

-4,947

-4

-5,564

-5,649

-5,562

-4,456

Interest income

258

35

1

68

19

24

27

16

24

33

29

7

13

10

3

5

-

0

1

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

24

-

-

-

-

-

Interest expense on convertible promissory notes and loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

558

551

-

Amortization of discount on convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,440

1,440

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

2

2

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-0

11

0

Interest expense on convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-545

Amortization of discount on convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,440

Net loss

-7,868

-7,584

-8,440

-9,700

-8,858

-8,522

-7,961

-9,753

-7,409

-6,716

-6,843

-7,548

-10,370

-8,489

-8,504

-5,816

-10,425

-4,666

-4,922

-4

-13,576

-7,644

-7,541

-6,438

Net loss per common share – basic and diluted

-2.05

-0.06

-0.07

-0.10

-3.82

-0.12

-0.12

-0.17

-0.13

-0.12

-0.12

-0.16

-0.25

-0.20

-0.23

-0.16

-0.15

-0.13

-0.14

-0.14

-0.50

-0.31

-0.32

-0.28

Weighted average shares outstanding – basic and diluted

-286,659

124,592

124,332

96,567

-159,045

68,763

64,418

59,052

103,249

56,799

56,513

46

115,922

42,220

37

35

142,441

35

35

35

-70,826

24,503

23,351

23,072